Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions

被引:126
作者
Li, CY
Dandridge, KS
Di, A
Marrs, KL
Harris, EL
Roy, K
Jackson, JS
Makarova, NV
Fujiwara, Y
Farrar, PL
Nelson, DJ
Tigyi, GJ
Naren, AP [1 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA
[2] Univ Tennessee, Hlth Sci Ctr, Dept Comparat Med, Memphis, TN 38163 USA
[3] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA
关键词
D O I
10.1084/jem.20050421
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel localized primarily at the apical or luminal surfaces of epithelial cells that line the airway, gut, and exocrine glands; it is well established that CFTR plays a pivotal role in cholera toxin (CTX)-induced secretory diarrhea. Lysophosphatidic acid (LPA), a naturally occurring phospholipid present in blood and foods, has been reported to play a vital role in a variety of conditions involving gastrointestinal wound repair, apoptosis, inflammatory bowel disease, and diarrhea. Here we show, for the first time, that type 2 LPA receptors (LPA(2)) are expressed at the apical surface of intestinal epithelial cells, where they form a macromolecular complex with Na+/H+ exchanger regulatory factor-2 and CFTR through a PSD95/Dlg/ZO-1-based interaction. LPA inhibited CFTR-dependent iodide efflux through LPA(2)-mediated G(i) pathway, and LPA inhibited CFTR-mediated short-circuit currents in a compartmentalized fashion. CFTR-dependent intestinal fluid secretion induced by CTX in mice was reduced substantially by LPA administration; disruption of this complex using a cell-permeant LPA(2)-specific peptide reversed LPA(2)-mediated inhibition. Thus, LPA-rich foods may represent an alternative method of treating certain forms of diarrhea.
引用
收藏
页码:975 / 986
页数:12
相关论文
共 58 条
  • [1] Serum lysophosphatidic acid is produced through diverse phospholipase pathways
    Aoki, J
    Taira, A
    Takanezawa, Y
    Kishi, Y
    Hama, K
    Kishimoto, T
    Mizuno, K
    Saku, K
    Taguchi, R
    Arai, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) : 48737 - 48744
  • [2] Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry
    Baker, DL
    Desiderio, DM
    Miller, DD
    Tolley, B
    Tigyi, GJ
    [J]. ANALYTICAL BIOCHEMISTRY, 2001, 292 (02) : 287 - 295
  • [3] Chloride secretion by the intestinal epithelium: Molecular basis and regulatory aspects
    Barrett, KE
    Keely, SJ
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 2000, 62 : 535 - 572
  • [4] Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease
    Bassaganya-Riera, J
    Reynolds, K
    Martino-Catt, S
    Cui, YZ
    Hennighausen, L
    Gonzalez, F
    Rohrer, J
    Benninghoff, AU
    Hontecillas, R
    [J]. GASTROENTEROLOGY, 2004, 127 (03) : 777 - 791
  • [5] BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705
  • [6] BOKOCH GM, 1983, J BIOL CHEM, V258, P2072
  • [7] Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids
    Bowman, CC
    Clements, JD
    [J]. INFECTION AND IMMUNITY, 2001, 69 (03) : 1528 - 1535
  • [8] Chang SY, 2002, J CELL SCI, V115, P783
  • [9] CHANG XB, 1993, J BIOL CHEM, V268, P11304
  • [10] ACTIVATED EOSINOPHILS IN CHRONIC INFLAMMATORY BOWEL-DISEASE
    CHOY, MY
    WALKERSMITH, JA
    WILLIAMS, CB
    MACDONALD, TT
    [J]. LANCET, 1990, 336 (8707) : 126 - 127